This case demonstrates that with careful multidisciplinary planning and individualized treatment strategies, it is feasible to achieve both successful maternal oncologic control and the delivery of a healthy baby in patients with HER-2 overexpressing breast cancer during pregnancy. This case contributes valuable evidence to the management of this complex clinical scenario.
Li et al. (Thu,) studied this question.